BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 11600541)

  • 1. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study.
    Kimpimäki T; Kupila A; Hämäläinen AM; Kukko M; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4782-8. PubMed ID: 11600541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of beta-cell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.
    Kimpimäki T; Kulmala P; Savola K; Kupila A; Korhonen S; Simell T; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4572-9. PubMed ID: 12364437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term exclusive breastfeeding predisposes young children with increased genetic risk of Type I diabetes to progressive beta-cell autoimmunity.
    Kimpimäki T; Erkkola M; Korhonen S; Kupila A; Virtanen SM; Ilonen J; Simell O; Knip M
    Diabetologia; 2001 Jan; 44(1):63-9. PubMed ID: 11206413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
    Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
    Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial clustering of beta-cell autoimmunity in initially non-diabetic children.
    Kukko M; Toivonen A; Kupila A; Korhonen S; Keskinen P; Veijola R; Virtanen SM; Ilonen J; Simell O; Knip M
    Diabetes Metab Res Rev; 2006; 22(1):53-8. PubMed ID: 16100734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signs of beta-cell autoimmunity and HLA-defined diabetes susceptibility in the Finnish population: the sib cohort from the Type 1 Diabetes Prediction and Prevention Study.
    Kukko M; Kimpimäki T; Kupila A; Korhonen S; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
    Diabetologia; 2003 Jan; 46(1):65-70. PubMed ID: 12637984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population.
    Kukko M; Kimpimäki T; Korhonen S; Kupila A; Simell S; Veijola R; Simell T; Ilonen J; Simell O; Knip M
    J Clin Endocrinol Metab; 2005 May; 90(5):2712-7. PubMed ID: 15872335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographical variation in risk HLA-DQB1 genotypes for type 1 diabetes and signs of beta-cell autoimmunity in a high-incidence country.
    Kukko M; Virtanen SM; Toivonen A; Simell S; Korhonen S; Ilonen J; Simel O; Knip M
    Diabetes Care; 2004 Mar; 27(3):676-81. PubMed ID: 14988284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DAQ1*0301-DQB1*0302 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. Belgian Diabetes Registry.
    Gorus FK; Vandewalle CL; Dorchy H; Van Crombrugge P; Schuit FC; Pipeleers DG
    J Clin Endocrinol Metab; 1994 May; 78(5):1172-8. PubMed ID: 8175975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of HLA class II, insulin and CTLA4 gene regions on the development of humoral beta cell autoimmunity.
    Hermann R; Laine AP; Veijola R; Vahlberg T; Simell S; Lähde J; Simell O; Knip M; Ilonen J
    Diabetologia; 2005 Sep; 48(9):1766-75. PubMed ID: 16025255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
    Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
    Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Reijonen H; Vähäsalo P; Sabbah E; Kulmala P; Ilonen J; Akerblom HK; Knip M
    J Clin Invest; 1996 Dec; 98(11):2489-95. PubMed ID: 8958211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Karlsburg type 1 diabetes risk study of a normal schoolchild population: association of beta-cell autoantibodies and human leukocyte antigen-DQB1 alleles in antibody-positive individuals.
    Schlosser M; Strebelow M; Wassmuth R; Arnold ML; Breunig I; Rjasanowski I; Ziegler B; Ziegler M
    J Clin Endocrinol Metab; 2002 May; 87(5):2254-61. PubMed ID: 11994372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group.
    Kimpimäki T; Kulmala P; Savola K; Vähäsalo P; Reijonen H; Ilonen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1126-32. PubMed ID: 10720050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune and clinical characteristics of type I diabetes in children with different genetic risk loads defined by HLA-DQB1 alleles. Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Sabbah E; Vähäsalo P; Lounamaa R; Akerblom HK; Reijonen H; Ilonen J
    Clin Sci (Lond); 1998 Mar; 94(3):263-9. PubMed ID: 9616260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported lower respiratory tract infections and development of islet autoimmunity in children with the type 1 diabetes high-risk HLA genotype: the MIDIA study.
    Rasmussen T; Witsø E; Tapia G; Stene LC; Rønningen KS
    Diabetes Metab Res Rev; 2011 Nov; 27(8):834-7. PubMed ID: 22069269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Timing of initial cereal exposure in infancy and risk of islet autoimmunity.
    Norris JM; Barriga K; Klingensmith G; Hoffman M; Eisenbarth GS; Erlich HA; Rewers M
    JAMA; 2003 Oct; 290(13):1713-20. PubMed ID: 14519705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
    Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.
    Sioofy-Khojine AB; Lehtonen J; Nurminen N; Laitinen OH; Oikarinen S; Huhtala H; Pakkanen O; Ruokoranta T; Hankaniemi MM; Toppari J; Vähä-Mäkilä M; Ilonen J; Veijola R; Knip M; Hyöty H
    Diabetologia; 2018 May; 61(5):1193-1202. PubMed ID: 29404673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.